Back
Argan, Inc. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Buy
63
AGX
Argan, Inc.
Last Price:
$306.00
Seasonality Move:
4.84%
Buy
65
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$111.47
Seasonality Move:
-9.01%
Buy
63
Argan, Inc. (AGX)
is a Buy
Is Argan, Inc. a Buy, Sell or Hold?
-
The current Argan, Inc. [AGX] share price is $320.10. The Score for AGX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
AGX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $112.45. The Score for RYTM is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AGX Stock Price Chart
What is Argan, Inc.'s stock price today?
-
The Argan, Inc. share price today is $320.10Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGX is experiencing slight buying pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $112.45Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
AGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.5 | Sell |
| Relative Strength Index (14 RSI): | 45.57 | Sell |
| Chaikin Money Flow: | 19092 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (325.53 - 367.83) | Sell |
| Bollinger Bands (100): | (230.65 - 328.37) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.16 | Buy |
| Relative Strength Index (14 RSI): | 57.91 | Buy |
| Chaikin Money Flow: | -333836 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (99.58 - 110) | Buy |
| Bollinger Bands (100): | (94.54 - 108.24) | Buy |
AGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 322.48 | Sell |
| 20-day SMA: | 346.07 | Sell |
| 50-day SMA: | 320.5 | Sell |
| 200-day SMA: | 226.8 | Buy |
| 8-day EMA: | 327.17 | Sell |
| 20-day EMA: | 334.57 | Sell |
| 50-day EMA: | 318.9 | Buy |
| 200-day EMA: | 243.33 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 108.93 | Buy |
| 20-day SMA: | 106.3 | Buy |
| 50-day SMA: | 105.7 | Buy |
| 200-day SMA: | 82.33 | Buy |
| 8-day EMA: | 110.1 | Buy |
| 20-day EMA: | 107.3 | Buy |
| 50-day EMA: | 104.59 | Buy |
| 200-day EMA: | 87.16 | Buy |
Argan, Inc. Earnings Growth & AGX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.14 per share, an increase this year of $2.73 per share, and an increase next year of $3.30 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.
Argan, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||